...
首页> 外文期刊>Clinics in dermatology >Effective prescribing in steroid allergy: controversies and cross-reactions.
【24h】

Effective prescribing in steroid allergy: controversies and cross-reactions.

机译:有效处方类固醇过敏:争议和交叉反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Contact allergy to topical corticosteroids should be considered in all patients who do not respond to, or are made worse by, the use of topical steroids. The incidence of steroid allergy in such patients is reported as 9% to 22% in adult patients and in 25% of children. It can often go undiagnosed for a long time in patients with a long history of dermatologic conditions and steroid use. Although rare, both immediate and delayed-type hypersensitivity reactions have been reported to systemic corticosteroids with an incidence of 0.3%. Reported reactions range from localized eczematous eruptions to systemic reactions, anaphylaxis, and even death. Delayed type reactions to systemically administered steroids may present as a generalized dermatitis, an exanthematous eruption, or occasionally, with blistering or purpura. In this contribution, we clarify the issues surrounding the pathogenesis of steroid allergy, cover the importance of cross-reactions, and describe strategies for the investigation and management for patients with suspected steroid allergy.
机译:所有对局部类固醇无反应或因使用局部类固醇而恶化的患者应考虑对局部皮质类固醇的接触过敏。据报道,此类患者中类固醇过敏的发生率在成年患者中为9%至22%,在儿童中为25%。对于长期皮肤病史和类固醇使用史的患者,通常很长一段时间都无法诊断。尽管很少见,但已报道全身性皮质类固醇的即刻型和迟发型超敏反应均发生,发生率为0.3%。报告的反应范围从局部的湿疹发作到全身反应,过敏反应甚至死亡。全身性类固醇的迟发型反应可能表现为全身性皮炎,发疹性皮疹或偶尔出现水疱或紫癜。在这项贡献中,我们阐明了类固醇过敏的发病机理,涵盖了交叉反应的重要性,并描述了对可疑类固醇过敏的患者进行调查和管理的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号